FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

317487000: Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693526017 Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3693528016 Ispaghula husk 900 mg/g granules for oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Is a Ispaghula husk granules false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ispaghula husk (substance) false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Has manufactured dose form A solid dose form consisting of dry aggregates of powder particles that are sufficiently resistant to withstand handling. false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antilipemic agent (substance) false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Has manufactured dose form Oral granules false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Is a Product containing ispaghula husk (medicinal product) false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Is a Product manufactured as oral dose form (product) false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Has concentration strength numerator value 900 false Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Count of base of active ingredient un false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Has concentration strength denominator value un false Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Ispaghula husk (substance) true Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Has manufactured dose form Granules for oral suspension true Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Ispaghula husk (substance) true Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) This attribute specifies the denominator unit for the concentration strength of a product. g true Inferred relationship Some 1
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Plays role Laxative therapeutic role false Inferred relationship Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) Is a Product containing only ispaghula husk in oral dose form (medicinal product form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start